C Citigroup Inc.

Citi Appointed Depositary Bank for Verona Pharma’s ADR Programme

LONDON--(BUSINESS WIRE)--

Citi, acting through Citibank N.A., has been appointed by Verona Pharma plc (“Verona Pharma”) as depositary bank for its American Depositary Receipt (“ADR”) programme. Verona Pharma’s ADRs trade on the NASDAQ Global Market under the symbol “VRNA.” Each ADR represents 8 ordinary shares of Verona Pharma. Verona Pharma’s ordinary shares continue to be admitted to trading on the London Stock Exchange’s AIM market under the symbol “VRP.”

“Citi is delighted to be appointed by Verona Pharma as depositary bank for its Nasdaq listed ADR programme,” said Dirk Jones, Global Head of Issuer Services, at Citi. “We are confident that we will be able to assist Verona Pharma in expanding their investor outreach through the support of our Investor Relations Advisory team and our unparalleled equity distribution network.”

For more information on Citi’s Depositary Receipt Services, visit www.citi.com/dr.

About Verona Pharma

Verona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs. Verona Pharma’s product candidate, RPL554, is a first-in-class, inhaled, dual inhibitor of the enzymes phosphodiesterase 3 and 4 that acts as both a bronchodilator and an anti inflammatory agent in a single compound. Verona Pharma is developing RPL554 for the treatment of chronic obstructive pulmonary disease (COPD), cystic fibrosis, and potentially asthma.

About Citi

Citi, the leading global bank, has approximately 200 million customer accounts and does business in more than 160 countries and jurisdictions. Citi provides consumers, corporations, governments and institutions with a broad range of financial products and services, including consumer banking and credit, corporate and investment banking, securities brokerage, transaction services, and wealth management.

Additional information may be found at www.citigroup.com | Twitter: @Citi | YouTube: www.youtube.com/citi | Blog: http://new.citi.com | Facebook: www.facebook.com/citi | LinkedIn: www.linkedin.com/company/citi

EN
03/05/2017

Underlying

CCitigroup Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Citigroup Inc.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 42.72
BAC BANK OF AMERICA...
MS MORGAN STANLEY ... (+7)

Vermilion Compass: Weekly Equity Strategy

Momentum Starting to Wane? We remain near-term bullish since our 4/22/25 Compass, and our intermediate-term out-look remains bullish as well (as of our 5/14/25 Compass). It is important to note that markets do not always maintain their upward trajectory at the same pace that we have seen over the last 2-month. We would welcome pullbacks and corrective action to take place. Our nearterm bullish outlook will remain in place long as the S&P 500 (SPX), Nasdaq 100 (QQQ), and Russell 2000 (IWM) are ab...

BAC BANK OF AMERICA CORP
MS MORGAN STANLEY
C CITIGROUP INC.
CMC JPMORGAN CHASE & CO.
GS GOLDMAN SACHS GROUP INC.
ARKX ARK SPACE EXPLORATION & INNOVATION ETF
ARKW BMO ARK NEXT GENERATION INTERNET FUND
07/08/25 July 8, 2025 1 EN
Free Trial
C CITIGROUP INC.

Citigroup Inc: 1 director

A director at Citigroup Inc sold 4,417 shares at 68.257USD and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...

05/03/25 May 3, 2025 1 EN
MarketLine Department
  • MarketLine Department
EUR 299.01
C CITIGROUP INC.

WesBanco, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliance...

Summary Marketline's WesBanco, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by WesBanco, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments repor...

04/21/25 April 21, 2025 1 EN
EUR 170.86
C CITIGROUP INC.

Citigroup Inc.: Solid year-over-year revenue growth continues to impro...

Return on TCE was 6.1% in Q4, down from 7.0% in Q3 and below its 10-11% 2026 target. However, all five non-legacy segments reported positive annual operating leverage, a credit positive.

01/15/25 January 15, 2025 1 EN
EUR 213.58
C CITIGROUP INC.

Citigroup Global Markets Inc.: Update to credit analysis following rat...

Our credit view of this issuer reflects its liquid, rapidly turning balance sheet, against its reliance on wholesale funding.

11/21/24 November 21, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch